Isabella Rimoldi
Overview
Explore the profile of Isabella Rimoldi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rimoldi I, Coffetti G, Gandolfi R, Facchetti G
Molecules
. 2024 Nov;
29(21).
PMID: 39519731
Carbon-carbon bond formation represents a key reaction in organic synthesis, resulting in paramount importance for constructing the carbon backbone of organic molecules. However, traditional metal-based catalysis, despite its advantages, often...
2.
Caligiuri R, Massai L, Geri A, Ricciardi L, Godbert N, Facchetti G, et al.
Dalton Trans
. 2024 Jan;
53(6):2602-2618.
PMID: 38223973
Many efforts have been made in the last few decades to selectively transport antitumor agents to their potential target sites with the aim to improve efficacy and selectivity. Indeed, this...
3.
Vaghi F, Facchetti G, Rimoldi I, Bottiglieri M, Contini A, Luisa Gelmi M, et al.
Front Chem
. 2023 Aug;
11:1233097.
PMID: 37638101
Many studies have demonstrated how the pyrrolidine nucleus is more efficient than the corresponding piperidine or morpholine as organocatalysts in the condensation of aldehydes with electrophiles enamine. Focussing on morpholine-enamines,...
4.
Coffetti G, Moraschi M, Facchetti G, Rimoldi I
Molecules
. 2023 Apr;
28(8).
PMID: 37110640
One of the main problems in chemotherapy using platinum drugs as anticancer agents is the resistance phenomenon. Synthesizing and evaluating valid alternative compounds is challenging. This review focuses on the...
5.
Sancho-Albero M, Facchetti G, Panini N, Meroni M, Bello E, Rimoldi I, et al.
Adv Healthc Mater
. 2023 Mar;
12(17):e2202932.
PMID: 36908188
Platinum-based chemotherapy is the first-line treatment for different cancer types, and in particular, for malignant pleural mesothelioma patients (a tumor histotype with urgent medical needs). Herein, a strategy is presented...
6.
Facchetti G, Neva F, Coffetti G, Rimoldi I
Molecules
. 2023 Feb;
28(4).
PMID: 36838894
Chiral diamines based on an 8-amino-5,6,7,8-tetrahydroquinoline backbone, known as CAMPY (), or the 2-methyl substituted analogue Me-CAMPY () were employed as novel ligands in Cp* metal complexes for the ATH...
7.
Caligiuri R, di Maio G, Godbert N, Scarpelli F, Candreva A, Rimoldi I, et al.
Dalton Trans
. 2022 Oct;
51(43):16545-16556.
PMID: 36254967
A series of novel cationic curcumin-based Pt(II) complexes with neutral (N^N) ligands and triflate anions as counterions, [(N^N)Pt(curc)]CFSO, 1-4, were synthesised and fully characterised. The antioxidant radical scavenging activity of...
8.
Mazzone G, Scoditti S, Caligiuri R, Ricciardi L, Sicilia E, Lupo M, et al.
Inorg Chem
. 2022 Apr;
61(18):7188-7200.
PMID: 35467854
Platinum compounds cytotoxicity is strictly related to their ability to be converted into active mono- and di-aquated species and consequently to the replacement of labile ligands by water molecules. This...
9.
Cocce V, Rimoldi I, Facchetti G, Ciusani E, Alessandri G, Signorini L, et al.
Pharmaceutics
. 2021 Dec;
13(12).
PMID: 34959382
A new cationic Pt(II) complex bearing 8-aminoquinoline as chelating ligand (called Pt-8AQ) was evaluated against two human carcinomas, one mesothelioma, and three glioblastoma cell lines. The in vitro comparison to...
10.
Sacco F, Tarchi M, Ferraro G, Merlino A, Facchetti G, Rimoldi I, et al.
Int J Mol Sci
. 2021 Oct;
22(19).
PMID: 34638887
Three novel platinum(II) complexes bearing N-heterocyclic ligands, i.e., Pt2c, Pt-IV and Pt-VIII, were previously prepared and characterized. They manifested promising in vitro anticancer properties associated with non-conventional modes of action....